These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 16867875)
1. Prognostic value of cell motility activation factors in patients with tongue squamous cell carcinoma. Endo K; Shirai A; Furukawa M; Yoshizaki T Hum Pathol; 2006 Aug; 37(8):1111-6. PubMed ID: 16867875 [TBL] [Abstract][Full Text] [Related]
2. Overexpression of c-Met promotes invasion and metastasis of small oral tongue carcinoma. Lim YC; Han JH; Kang HJ; Kim YS; Lee BH; Choi EC; Kim CH Oral Oncol; 2012 Nov; 48(11):1114-9. PubMed ID: 22704061 [TBL] [Abstract][Full Text] [Related]
3. Correlation between loss of E-cadherin expression and overexpression of autocrine motility factor receptor in association with progression of human gastric cancers. Kawanishi K; Doki Y; Shiozaki H; Yano M; Inoue M; Fukuchi N; Utsunomiya T; Watanabe H; Monden M Am J Clin Pathol; 2000 Feb; 113(2):266-74. PubMed ID: 10664629 [TBL] [Abstract][Full Text] [Related]
4. The relation between the growth patterns of gastric carcinoma and the expression of hepatocyte growth factor receptor (c-met), autocrine motility factor receptor, and urokinase-type plasminogen activator receptor. Taniguchi K; Yonemura Y; Nojima N; Hirono Y; Fushida S; Fujimura T; Miwa K; Endo Y; Yamamoto H; Watanabe H Cancer; 1998 Jun; 82(11):2112-22. PubMed ID: 9610690 [TBL] [Abstract][Full Text] [Related]
5. Elevated expression of autocrine motility factor receptor correlates with overexpression of RhoC and indicates poor prognosis in hepatocellular carcinoma. Wang W; Yang LY; Yang ZL; Peng JX; Yang JQ Dig Dis Sci; 2007 Mar; 52(3):770-5. PubMed ID: 17265125 [TBL] [Abstract][Full Text] [Related]
6. c-Met expression as an indicator of survival outcome in patients with oral tongue carcinoma. Kim CH; Koh YW; Han JH; Kim JW; Lee JS; Baek SJ; Hwang HS; Choi EC Head Neck; 2010 Dec; 32(12):1655-64. PubMed ID: 20848408 [TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of autocrine motility factor receptor expression by colorectal cancer and lymph node metastases. Halwani Y; Kojic LD; Chan SK; Phang TP; Masoudi H; Jones SJ; Nabi IR; Wiseman SM Am J Surg; 2015 May; 209(5):884-9; discussion 889. PubMed ID: 25852009 [TBL] [Abstract][Full Text] [Related]
8. The expression of vascular endothelial growth factor-A and -C, and receptors 1 and 3: correlation with lymph node metastasis and prognosis in tongue squamous cell carcinoma. Tanigaki Y; Nagashima Y; Kitamura Y; Matsuda H; Mikami Y; Tsukuda M Int J Mol Med; 2004 Sep; 14(3):389-95. PubMed ID: 15289890 [TBL] [Abstract][Full Text] [Related]
9. Autocrine motility factor receptor: a clinical review. Chiu CG; St-Pierre P; Nabi IR; Wiseman SM Expert Rev Anticancer Ther; 2008 Feb; 8(2):207-17. PubMed ID: 18279062 [TBL] [Abstract][Full Text] [Related]
11. Aberrant expression of the autocrine motility factor receptor correlates with poor prognosis and promotes metastasis in gastric carcinoma. Huang Z; Zhang N; Zha L; Mao HC; Chen X; Xiang JF; Zhang H; Wang ZW Asian Pac J Cancer Prev; 2014; 15(2):989-97. PubMed ID: 24568530 [TBL] [Abstract][Full Text] [Related]
12. Autocrine motility factor receptor expression implies an unfavourable prognosis in resected stage I pulmonary adenocarcinomas. Kaynak K; Kara M; Oz B; Akgoz B; Sar M; Raz A Acta Chir Belg; 2005 Aug; 105(4):378-82. PubMed ID: 16184720 [TBL] [Abstract][Full Text] [Related]
13. [Survival analysis of 229 patients with advanced squamous cell carcinoma of the oral tongue]. Yang AK; Liu TR; Chen FJ; Ma XF; Guo ZM; Song M; Li QL; Zeng ZY Ai Zheng; 2008 Dec; 27(12):1315-20. PubMed ID: 19080001 [TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of biomarkers in squamous cell carcinoma of the tongue: multivariate analysis. Vora HH; Shah NG; Patel DD; Trivedi TI; Chikhlikar PR J Surg Oncol; 2003 Jan; 82(1):34-50. PubMed ID: 12501167 [TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor C (VEGF-C) expression predicts metastasis in tongue cancer. Matsui T; Shigeta T; Umeda M; Komori T Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Oct; 120(4):436-42. PubMed ID: 26216169 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of circulating c-met messenger RNA is significantly correlated with nodal stage and early recurrence in non-small cell lung cancer. Cheng TL; Chang MY; Huang SY; Sheu CC; Kao EL; Cheng YJ; Chong IW Chest; 2005 Sep; 128(3):1453-60. PubMed ID: 16162743 [TBL] [Abstract][Full Text] [Related]
17. [Relevant factors and management for patients with squamous carcinoma in tongue without clinical cervical lymphatic node metastasis]. Lin GC; Qiu WL; Zhang ZY; Zhang CP; Zu HG; Sun J Zhonghua Kou Qiang Yi Xue Za Zhi; 2003 Jan; 38(1):5-8. PubMed ID: 12760766 [TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of Ets-1 overexpression in betel and tobacco related oral cancer. Pande P; Soni S; Chakravarti N; Mathur M; Shukla NK; Ralhan R Cancer Detect Prev; 2001; 25(5):496-501. PubMed ID: 11718456 [TBL] [Abstract][Full Text] [Related]
19. Survival pattern and prognostic factors of patients with squamous cell carcinoma of the tongue: a retrospective analysis of 210 cases. Ling W; Mijiti A; Moming A J Oral Maxillofac Surg; 2013 Apr; 71(4):775-85. PubMed ID: 23265849 [TBL] [Abstract][Full Text] [Related]
20. Predictive markers for late cervical metastasis in stage I and II invasive squamous cell carcinoma of the oral tongue. Lim SC; Zhang S; Ishii G; Endoh Y; Kodama K; Miyamoto S; Hayashi R; Ebihara S; Cho JS; Ochiai A Clin Cancer Res; 2004 Jan; 10(1 Pt 1):166-72. PubMed ID: 14734465 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]